Abstract:Author(s): Fares-Frederickson, Nancy | Advisor(s): David, Michael | Abstract: Interferon regulatory factor 3 (IRF3) is a transcription factor found in the cytoplasm of most nucleated cells. Upon pathogen detection by pattern recognition receptors, IRF3 becomes activated and translocates to the nucleus where it mediates the production of type I interferon (IFN) and IFN-stimulated genes. The collective actions of these genes induce an antimicrobial state within infected and neighboring cells, allowing for pathogen clearance. Whereas the type I IFN system has been studied extensively in the context of pathogen responses, it has more recently become appreciated for its role in immune cell modulation. In this report we discuss novel findings highlighting the involvement of the type I IFN system—with a focus on IRF3—in T cell development, activation, differentiation, and cytokine production.Using a combination of in vitro assays and in vivo disease models, we demonstrate that IRF3 is a positive regulator of lL-17 and IFN-γ in CD4+ T cells. We show that IRF3-deficient CD4+ T cells have impaired production of the pro-inflammatory cytokines IL-17 and IFN-γ, and are unable to induce disease in the T cell transfer model of colitis. Unexpectedly, we observed IRF3 nuclear translocation in activated T cells. To our knowledge, this is the first description of IRF3 activation following T cell receptor stimulation. These results, which are the focus of chapter 1, reveal a previously unappreciated role for IRF3 in CD4+ T cell responses and extend its role beyond the innate immune response to pathogens.Additionally, we show that type I IFN limits T cell production of IL-2—a cytokine required for T cell activation and expansion—by indirectly altering histone modifications in the IL-2 promoter to retain the locus in an inaccessible configuration. These results, which are the focus of chapter 2, help explain why type I IFN has been an effective treatment for multiple sclerosis—a T cell- mediated autoimmune condition.

IRF3-dependent type I interferon response in B cells regulates CpG-mediated antibody production

TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses Through a Noncytotoxic Mechanism

B lymphocytes enhance interferon-α production by plasmacytoid dendritic cells

Regulation of IFN-gamma production by B effector 1 cells: essential roles for T-bet and the IFN-gamma receptor

Plasmacytoid Dendritic Cells and Type I Interferon Promote Extrafollicular B Cell Responses to Extracellular Self-DNA

Type I interferon promotes the fate of Toll-like receptor 9–stimulated follicular B cells to plasma cell differentiation

B Cell Activation and Plasma Cell Differentiation Are Promoted by IFN-λ in Systemic Lupus Erythematosus

Bacterial Cpg Induces Hyper-Igm Production in Cd27(+) Memory B Cells in Primary Biliary Cirrhosis

Type I IFN Drives Experimental Systemic Lupus Erythematosus by Distinct Mechanisms in CD4 T Cells and B Cells

Transcription Factor IRF4 Regulates Germinal Center Cell Formation through a B Cell–Intrinsic Mechanism

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients

Cutting Edge: Intracellular IFN-β and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells

Beyond Innate Immunity: Defining a Role for Interferon Regulatory Factor 3 in CD4+ T Cell Responses

B cell autophagy mediates TLR7-dependent autoimmunity and inflammation

B cells play a crucial role as antigen-presenting cells and collaborate with inflammatory cytokines in glucose-6-phosphate isomerase-induced arthritis

Dysregulation of type I IFN and IL-4R signaling regulates the development of BCR VH and VL repertoire encoding anti-Sm autoantibodies in SLE

Regulation of cytokine expression by an autoreactive B cell clone derived from MRL/MP-lpr/lpr mice

Regulation of B Cell Fate by Chronic Activity of the IgE B Cell Receptor.

Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus

Integrin αvβ3 Limits Cytokine Production by Plasmacytoid Dendritic Cells and Restricts TLR-Driven Autoimmunity